Paolo Caraceni

Full Professor of Internal Medicine

University of Bologna

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Paolo Caraceni is a Full Professor of Internal Medicine at the University of Bologna, Italy. His research focuses on hepatorenal syndrome, acute decompensation of cirrhosis, and multidrug-resistant bacterial infections in cirrhotic patients. Recent publications include studies on albumin infusion, myosteatosis, and predictors of clinical outcomes in patients with cirrhosis.

Articles (14)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (10)

Salvatore Piano

University of Padova

ITALY

View details

Rajeshwar Prosad Mookerjee

UNITED KINGDOM

View details

Aleksander Krag

Odense University Hospital

DENMARK

View details

Dario Saltini

University of Modena and Reggio Emilia

ITALY

View details

Sung Eun Kim

Hallym University Sacred Heart Hospital

SOUTH KOREA

View details

Pierluigi Toniutto

prof.

ITALY

View details

Giorgio Bedogni

Associate Professor of Internal Medicine

ALMA MATER STUDIORUM UNIVERSITY OF BOLOGNA

ITALY

View details

Gaetano Bertino

Associate Professor of Gastroenterology

University of Catania

ITALY

View details

Francesco Palmese

University of Bologna

ITALY

View details

Giacomo Zaccherini

University of Bologna

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Paolo Caraceni

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Albumin infusion in hepatorenal syndrome-acute kidney injury: New evidence challenges recent consensus

Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis

Development and external validation of a model to predict multidrug‐resistant bacterial infections in patients with cirrhosis

Albumin in hospitalized patients with complications of cirrhosis: Not a suit for all seasons

Predictors of clinical trajectories of patients with acutely decompensated cirrhosis. An external validation of the PREDICT study

Low haemoglobin level predicts early hospital readmission in patients with cirrhosis and acute decompensation

Mortality and its association with chronic alcohol-related diseases in patients admitted to the emergency department for acute alcoholic intoxication: retrospective cohort study

Mechanisms and treatment approaches for ACLF

A case of peri‑stomal ectopic variceal bleeding in a patient with decompensated cirrhosis treated with TIPS placement

Correction and Prevention of Hyponatremia in Patients With Cirrhosis and Ascites: Post Hoc Analysis of the ANSWER Study Database

Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma

Letter to the editor: RECAM for the diagnosis of DILI—Is it time to incorporate additional pharmacological criteria?

Liver Injury with Nintedanib: A Pharmacovigilance– Pharmacokinetic Appraisal

Long-term albumin treatment in patients with cirrhosis and ascites

Collaborators (10)

Salvatore Piano

Rajeshwar Prosad Mookerjee

Aleksander Krag

Dario Saltini

Sung Eun Kim

Pierluigi Toniutto

Giorgio Bedogni

Gaetano Bertino

Francesco Palmese

Giacomo Zaccherini

Make your next move.